PRIMECAP Management's position in Health Catalyst is currently worth $8.28 Million. That's 0.01% of their equity portfolio (253rd largest holding). The investor owns 2.88% of the outstanding Health Catalyst stock. The first Health Catalyst trade was made in Q2 2020. Since then PRIMECAP Management bought shares sixteen more times and sold shares on three occasions. The investor's estimated purchase price is $26.3 Million, resulting in a loss of 69%.
… funds and other institutional investors also recently modified their … worth $26,000. WealthPlan Investment Management LLC acquired a new … during the peri...
eVisit closes USD45m in Series B funding round led by Goldman Sachs Asset Management Submitted 22/09/2021 - 9:41am eVisit, a Virtual Care platform for large ...
SALT LAKE CITY, Feb. 2, 2021 /PRNewswire/ -- Vitalware by Health Catalyst today announced that its chargemaster management solution, VitalCDM, ranked number ...
Global Patient Safety And Risk Management Software Market: Overview Increased instances of medical errors together with growing inclination among healthcare ...